Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Knightscope
Sponsored
content by Knightscope
MA
MarketJar
Community Contributor
The Next Phase of Defense AI: A Robotic Response to America’s Security Gaps
Autonomous systems are no longer just a futuristic vision — they’re fast becoming an essential layer of national security. As AI reshapes everything from finance to warfare, physical security remains one of the most under-addressed frontiers.
View narrative
US$12.00
FV
54.3% undervalued
intrinsic discount
22.00%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
1
users have commented on this narrative
15
users have followed this narrative
New
narrative
Figma
TI
TickerTickle
Community Contributor
Figma (FIG): The S&P 500’s Design Standard Turning Into an All-in-One Platform
Watching Figma Grow Up I’ve been using Figma almost every single day for the past five years. As a product designer, it’s been my main tool for designing interfaces, testing and prototyping ideas, and also for working together with teams in different countries and time zones.
View narrative
US$65.70
FV
7.2% overvalued
intrinsic discount
30.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
Updated
narrative
Sleep Cycle
MA
Mandelman
Community Contributor
Sleep Cycle's Revenue Set to Rise 10% with Strong Revenue Model
Update Q1 2025 (updated 250510) The latest user‐growth data suggest headwinds for top-line revenue, but management’s active repricing initiatives should help offset this. By combining modest user gains with targeted price increases, the company can still drive overall revenue growth.
View narrative
SEK 38.04
FV
25.3% undervalued
intrinsic discount
3.15%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
23
users have followed this narrative
Updated
narrative
JB Hi-Fi
RO
Robbo
Community Contributor
Has JB Hi-Fi Lost Its Point of Difference?
I may be showing my age here, but I feel that a decade or so ago, shopping at JB Hi-Fi was a different experience. There seemed to be a deliberate policy of employing sales staff from alternative subcultures, which gave the stores a unique, edgy vibe.
View narrative
AU$76.00
FV
51.4% overvalued
intrinsic discount
-0.45%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Arcadia Biosciences
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Zola Distribution Expansion Will Unlock Enduring Market Strength
Key Takeaways Arcadia's focus on expanding Zola distribution and profitable product lines is set to drive revenue growth and improve earnings through high-margin sales. Strategic exits and IP monetization simplify operations, reduce expenses, and provide capital for growth, enhancing long-term financial stability.
View narrative
US$12.00
FV
67.0% undervalued
intrinsic discount
25.66%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
0
users have followed this narrative
11 days ago
author updated this narrative
Plus Therapeutics
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
15 Million Financing And Oncology Trials Will Secure Clinical Progress
Key Takeaways Strengthened financial position and leadership could drive clinical advancements, potentially boosting future revenue and improving earnings growth. Advancements and strategic partnerships indicate significant market opportunities, enhancing revenue potential and profit margins through reduced costs and expanded markets.
View narrative
US$9.17
FV
94.7% undervalued
intrinsic discount
98.26%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
11 days ago
author updated this narrative
Ontrak
AN
AnalystConsensusTarget
Consensus Narrative from Analysts
Intermountain Health And New Plans Will Redefine Value Care
Key Takeaways Securing new health plan customers and expanding existing ones promises revenue growth as partnerships mature and engagement increases. Transition to a value-based model may improve net margins by aligning incentives with medical cost savings.
View narrative
US$3.00
FV
96.7% undervalued
intrinsic discount
67.05%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
11 days ago
author updated this narrative
Jaguar Health
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
FDA And EMA Approvals Will Unlock Global Market Potential
Key Takeaways Successful clinical results and regulatory progress could unlock premium pricing, orphan drug exclusivity, and rapid market expansion for crofelemer across multiple rare indications. Strategic partnerships, business development, and traction in underserved specialty and animal health markets enhance long-term earnings potential and reduce reliance on equity funding.
View narrative
US$28.00
FV
93.6% undervalued
intrinsic discount
47.01%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
11 days ago
author updated this narrative
Air Industries Group
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Record 120M Backlog Will Fuel Aerospace And Defense Momentum
Key Takeaways Backlog growth, new contract wins, and global defense spending are set to drive sustained long-term revenue and support gradual earnings stability. Cost-control measures, workforce cuts, and improved balance sheet position the company for stronger profitability as higher-margin orders are fulfilled.
View narrative
US$6.50
FV
51.7% undervalued
intrinsic discount
2.62%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
11 days ago
author updated this narrative
NextEd Group
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Expanding High-Demand Courses Will Strengthen Future Position
Key Takeaways Focus on higher-margin courses and efficient campus utilization is expected to boost revenue and stabilize margins. Expanding in-demand course offerings aligns with trends, potentially enhancing future revenue streams and market position.
View narrative
AU$0.33
FV
32.3% undervalued
intrinsic discount
3.46%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
11 days ago
author updated this narrative
Bridgeline Digital
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Digital Transformation And AI Will Advance Omnichannel Solutions
Key Takeaways AI-driven features and strategic partnerships are boosting customer adoption, platform value, and creating new revenue streams through upselling and cross-selling opportunities. Growing recurring SaaS revenue and scalable, compliant solutions are improving revenue predictability, margins, and long-term profitability across enterprise digital markets.
View narrative
US$4.06
FV
65.8% undervalued
intrinsic discount
9.04%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
11 days ago
author updated this narrative
hGears
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
E-bike Normalization And Industrial Automation Will Fuel Future Turnaround
Key Takeaways Stabilizing e-bike component demand, growth in e-Tools, and exposure to electrification trends position hGears for future revenue and margin improvement. Operational efficiencies, cost controls, and strong OEM contracts enhance earnings resilience and free cash flow stability amid sector volatility.
View narrative
€1.80
FV
6.7% overvalued
intrinsic discount
7.56%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
11 days ago
author updated this narrative
Velocity Composites
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
US Onboarding And European Defense Expansion Will Drive Progress
Key Takeaways Expanding defense sector opportunities in North America and Europe could diversify revenue streams and increase earnings potential. Implementation of the Odoo-based MRP system standardizes operations and improves data management, enhancing operational efficiencies and net margins.
View narrative
UK£0.55
FV
58.2% undervalued
intrinsic discount
10.62%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
11 days ago
author updated this narrative
Value any company in seconds
Popular companies